Published by
@ShahidNShah
@ShahidNShah
Roundup: Taiwan approves VUNO's AI fundus tool and more briefs
The potential of AIRS Medical's AI MRI reconstruction tool to denoise and enhance the quality of 3D MR images has also been demonstrated. Taiwan's Food and Drug Administration has given South Korean company VUNO permission to market its AI fundus analysis software. To swiftly locate lesions suggestive of retinal disorders such diabetic retinopathy, macular disease, and glaucoma, VUNO Med-Fundus AI analyses images of the fundus. Following Taiwan FDA approval for two previous AI products, VUNO-Med Chest X-ray and VUNO-Med Bone Age, comes this most recent accreditation. VUNO only received Singapore's approval for VUNO Med-Fundus AI two months ago. A study supports AIRS Medical's use of artificial intelligence to denoise 3D MR pictures.
Continue reading at mobihealthnews.com
Make faster decisions with community advice
- Franciscan Health expands its Epic-linked telemedicine offerings
- HIMSS22 APAC Drives Healthcare Transformation in Bali, Reimagining Health
- Iveda® Launches IvedaCare, an AI-driven Assistant for Safety, Security, and Elderly Care
- Leading Healthcare Organizations Choose Qualtrics to Deliver Ease and Empathy to Patients and Caregivers - Qualtrics
- Motient Partners with the Choctaw Nation to Support Rural Patient Transfers
Next Article
-
5 takeaways from the FDA’s list of AI-enabled medical devices
This nice analysis shows that AI-enabled devices with FDA approval have are now relatively common. The FDA now has better capabilities to evaluate devices which use machine learning ("AI" is still …
Posted Dec 2, 2022 AI-Automation AI & Machine Learning AIOps (Artificial Intelligence for IT Operations)
